Discover: How Bayer Radically Reengineered its Operating Model to Ensure it was Fit to Thrive in an AI-Enabled Life Sciences Industry
- Inside the ‘dynamic shared ownership’ model which allows a 160-year-old entity with 100k headcount to operate with greater speed, agility and do more with less
- How 90-day cycles allow AI-enabled teams to set clearer outcomes, test new solutions, learn lessons faster, and adapt to new realities to help move forward faster
- Challenging traditional thinking about career paths in a future pharma workforce turn career ladders into zig zags and create more valuable, transferrable talent